title: Increase of IL-17, IL-22 and IL-23 serum levels induced by immunoglobulin infusion for Parvovirus-B associated Pure Red Cell Aplasia in a renal transplant recipient.
authors.forename: Andrea
authors.initials: A
authors.lastname: Alonci
authors.forename: Giuseppa
authors.initials: G
authors.lastname: Penna
authors.forename: Alessandro
authors.initials: A
authors.lastname: Allegra
authors.forename: Arianna
authors.initials: A
authors.lastname: D'Angelo
authors.forename: Sebastiano
authors.initials: S
authors.lastname: Gangemi
authors.forename: Maria
authors.initials: M
authors.lastname: Ferraro
authors.forename: Giovanna
authors.initials: G
authors.lastname: Spatari
authors.forename: Francesco
authors.initials: F
authors.lastname: Bacci
authors.forename: Demetrio
authors.initials: D
authors.lastname: Gerace
authors.forename: Caterina
authors.initials: C
authors.lastname: Musolino
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage*; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D020381:Interleukin-17 / Q000097:blood*; D053759:Interleukin-23 / Q000097:blood*; D007378:Interleukins / Q000097:blood*; D016030:Kidney Transplantation; D010322:Parvoviridae Infections / Q000097:blood / Q000150:complications* / Q000628:therapy; D016732:Parvovirus B19, Human / Q000302:isolation & purification; D012010:Red-Cell Aplasia, Pure / Q000209:etiology*; D000097043:Interleukin-22
chemical_list: D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D020381:Interleukin-17; D053759:Interleukin-23; D007378:Interleukins; D000097043:Interleukin-22